American clinical stage biopharmaceutical company based in Jacksonville, Florida, which develops antiviral medicines by repurposing known compounds. Works on host directed and direct acting antivirals for respiratory viral infection, taking its lead candidate into clinical trials for indications including respiratory syncytial virus and other viral respiratory disease, and carries out preclinical virology, formulation and clinical development with academic and government partners.
Aucun commentaire disponible.
Laissez votre note & commentaire